Update October 2026. Great feature story from Luxury Launches Magazine featuring the Jobs family – some never before seen pictures and new info on the story of YOSEMITE, Reed Jobs’ cancer initiative outlined below. Click here to read. The article claims he is managing roughly $1 billion and expanding into UK cancer research (I’m looking for detail of that).
Reed shared, “I saw my dad have cancer when I was a kid… that really motivated me to try to transform outcomes for other people.”
Update June 2026. HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the closing of a new financing round with participation from Reed Jobs and Yosemite, whose aim is to “make cancer non-lethal in our lifetime,” alongside several new strategic investors. Read more click here
Click here to read more about Histotripsy.
Update February 2026. Today, Yosemite said that it had raised more than $200 million for a second fund that has a total targeted size of $350 million, with heavy-hitter investors that include biotech giant Amgen, Memorial Sloan Kettering, MIT and venture capitalist John Doerr. Powell Jobs (Steve’s wife) invested in the fund through Emerson; as a general partner, Jobs is also personally invested. Read more click here.
Original story
Just about everyone knows who Steve Jobs is but not many people have heard of Reed Jobs. Clearly a relative and is actually his son. Now aged 31, he wants to get into the cancer business via a venture capitalist initiative. The headline below looks great but it means cancer, not just Neuroendocrine Cancer (note the use of Steve Jobs’ actual diagnosis).
I first heard about this and switched off after the news article stated that Steve Jobs had Pancreatic Cancer. Don’t get me wrong, I strongly believe that Pancreatic Cancer needs lots of attention and lots of funding and research. But so does Neuroendocrine Cancer including the actual cancer that Steve had, a Neuroendocrine Tumor of pancreatic origin.
The article which brought back my attention to the usual Steve Jobs saga, was the one I’m attaching below. Although it does not exclude Pancreatic Cancer from the wording, unlike the first one I read (and deleted), this one goes on to say Pancreatic Neuroendocrine Tumor. I’m sure I can find others both saying Pancreatic Cancer only or a bit of both. I’m really looking for one which only says Pancreatic Neuroendocrine Tumor.
The fund will be called Yosemite after the park where Steve Jobs and Lauren Powell got married. It has already received $200 million in contributions to the mission. Reed Jobs has a target of $400 million, which is “nearly 10 times the average size of a fund of new venture capitalists by 2022,” according to business insider.
Will we see some money going to Neuroendocrine Tumours? We will need to wait and see but I’d like to think that Reed Jobs as the initiator of a giant pot of money, will ensure his father finally has a legacy in the cancer world with Neuroendocrine Tumours having a big piece of skin in the game.
“Steve Jobs’ son launches millionaire fund to save people from his father’s illness”
Great headline but it means cancer rather than his actual cancer. It’s wonderful that all cancers might benefit though.
Read the article by clicking here.
The Steve Jobs cancer story
I’ve written about Steve in the article linked below and it’s managed to attract over 31,000 hits to date. I hope more sharing of this blog and his story below will attempt to stem the avalanche of pancreatic cancer/Steve Jobs stories which come out almost daily.
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
- A spotlight on NENs
- A spotlight on NENs – Syndromes
- A Spotlight on NENs – Testing Series
- A spotlight on NENs – Types
- A Spotlight on Vitamins & Minerals
- Awareness
- Clinical Trials and Research
- Diet and Nutrition
- Fundraising
- General
- Humour
- Inspiration
- Latest ENETS Guidelines
- Living with Neuroendocrine Cancer
- Newsletters
- Patient Advocacy
- Ronny Allan's "The Trouble with the NET Series"
- Sometimes you gotta climb that hill!
- Spotlight on NENs – Types Series
- Survivorship
- The NET Effect Series
- Travel with Ronny
- Treatment
- Ronny Allan’s Newsletter covering October 2026
Summary of October 2026 on RonnyAllan.NET October was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday. Still a reasonable blog performance – I can’t complain. Still managed to cover 3 new US FDA approvals! I had… Read more: Ronny Allan’s Newsletter covering October 2026 - I made it to 71!
I started doing the “Piss off cancer” or “I made it” series when I got to 65, mainly because I initially thought I wouldn’t make that age. I was 54 years and 9 months old at diagnosis on 26th July 2010. For the first few months, I had no idea what the outcome would be. … Read more: I made it to 71! - Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources?
The title of this blog is the form of a rhetorical question. Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources? I guess if you ask any patient, the answer is a resounding YES. I also very much guess that many doctors would repeat that answer. And some are… Read more: Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources? - Ronny Allan’s Newsletter covering September 2026
Summary of September 2026 on RonnyAllan.NET September was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday. Still a reasonable blog performance – I can’t complain. Still managed to cover 3 new US FDA approvals! I had… Read more: Ronny Allan’s Newsletter covering September 2026 - Amneal Lanreotide Approved by US FDA
Amneal launches first CGT‑designated U.S. generic lanreotide — what NET patients need to know Amneal has launched the first Competitive Generic Therapy (CGT)‑designated U.S. generic for lanreotide, a major milestone in a market long dominated by Ipsen’s Somatuline® Depot. The product — lanreotide injection 120 mg/0.5 mL in a sterile single‑dose prefilled syringe —… Read more: Amneal Lanreotide Approved by US FDA - Ronny Allan’s Newsletter covering August 2026
Summary of August 2026 on RonnyAllan.NET August was similar to the other months of this year but like July, views are down on the previous two months due to 50% of the month spent on holiday. Still a reasonable blog performance – I can’t complain. Other key targets met were three more editions of the Spotlight… Read more: Ronny Allan’s Newsletter covering August 2026 - External Beam Radiation Therapy (EBRT) for Neuroendocrine Neoplasms
Disclaimer: The information in this section is for education only and does not represent a standard care pathway or service. These treatments are not suitable for everyone, and careful patient selection by an experienced multidisciplinary team is essential. Always discuss your individual situation with your own specialist team. External Beam Radiation Therapy (EBRT) is… Read more: External Beam Radiation Therapy (EBRT) for Neuroendocrine Neoplasms - 2026 Surveillance Update from Ronny Allan: “See you in 12 months”
It’s only a couple of weeks since I celebrated my 16th year since diagnosis of metastatic small intestine Neuroendocrine Tumour (NET) at Grade 2 on 26th July 2010. Thinking back to that period of my life, I’m happy but also slightly amazed to be celebrating such a long milestone having been diagnosed with cancer at… Read more: 2026 Surveillance Update from Ronny Allan: “See you in 12 months”
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.
I’m glad to hear that Steve Jobs son has stepped up to the plate and acknowledged his father’s neuroendocrine cancer and is raising money to help find solutions. My father had neuroendocrine cancer from the year I was born until his death when I was 16. Do we know if Steve Jobs had a DNA mutation that his son could/has inherited. I learned I’d inherited my father’s when a tumor showed up at age fifty. SDHB part of the Krebs Cycle. I’ve survived 15 years by having 7 surgeries and being my own advocate to push research to find solutions and get surgeons to due complicated surgeries. My wouldn’t be alive if I hadn’t advocated for myself with my dad’s history as my “truth”.
I don’t remember seeing genetic stuff mentioned